AdvaMed wants to collaborate with the Trump administration to recognize and reward the unique strength of the U.S. medtech industry.
AdvaMed CEO and President Scott Whitaker stated that his group aims to work with the administration to implement supportive policies, including:
“to recognize and to reward the unique strength of the U.S. medtech industry”
AdvaMed submitted comments to Commerce Secretary Howard Lutnick, highlighting the domestic medtech industry's recent investments, employment growth, and R&D spending driving medical innovation.
Author's summary: AdvaMed seeks Trump administration support.